Xenon Pharmaceuticals Stock (NASDAQ: XENE)
|Day Range34.92 - 36.76||52 Wk Range24.6 - 41.39||Open / Close36.76 / 35.53||Float / Outstanding61.5M / 62.3M|
|Vol / Avg.343.7K / 505.1K||Mkt Cap2.2B||P/E-||50d Avg. Price36.5|
|Div / Yield-||Payout Ratio-||Total Float61.5M||EPS-0.35|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Xenon Pharmaceuticals (NASDAQ: XENE) through any online brokerage.
There are no as such competitors for Xenon Pharmaceuticals.
The latest price target for Xenon Pharmaceuticals (NASDAQ: XENE) was reported by B of A Securities on Monday, August 29, 2022. The analyst firm set a price target for 0.00 expecting XENE to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $35.53 last updated September 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Xenon Pharmaceuticals.
Xenon Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Xenon Pharmaceuticals.
Xenon Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.